CN1420763A - 每天给药一次环丙沙星的口服给药控释系统 - Google Patents

每天给药一次环丙沙星的口服给药控释系统 Download PDF

Info

Publication number
CN1420763A
CN1420763A CN01805998A CN01805998A CN1420763A CN 1420763 A CN1420763 A CN 1420763A CN 01805998 A CN01805998 A CN 01805998A CN 01805998 A CN01805998 A CN 01805998A CN 1420763 A CN1420763 A CN 1420763A
Authority
CN
China
Prior art keywords
ciprofloxacin
preparation according
xanthan gum
weight
sodium alginate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01805998A
Other languages
English (en)
Chinese (zh)
Inventor
N·塔尔瓦尔
J·N·斯塔尼福思
A·朗帕尔
G·慕克吉
B·N·维什瓦纳坦
B·贺拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of CN1420763A publication Critical patent/CN1420763A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN01805998A 2000-03-03 2001-02-28 每天给药一次环丙沙星的口服给药控释系统 Pending CN1420763A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
US09/517,887 2000-03-03

Publications (1)

Publication Number Publication Date
CN1420763A true CN1420763A (zh) 2003-05-28

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01805998A Pending CN1420763A (zh) 2000-03-03 2001-02-28 每天给药一次环丙沙星的口服给药控释系统

Country Status (31)

Country Link
EP (1) EP1263409A1 (pl)
JP (1) JP2003525229A (pl)
KR (1) KR20030009374A (pl)
CN (1) CN1420763A (pl)
AP (2) AP2001002084A0 (pl)
AR (1) AR032614A1 (pl)
AU (1) AU3589701A (pl)
BG (1) BG107055A (pl)
BR (1) BR0108958A (pl)
CA (1) CA2400950A1 (pl)
CZ (1) CZ20022883A3 (pl)
DO (1) DOP2001000130A (pl)
EA (1) EA200200914A1 (pl)
EC (1) ECSP013952A (pl)
EE (1) EE200200497A (pl)
GT (1) GT200100033A (pl)
HN (1) HN2001000038A (pl)
HR (1) HRP20020715A2 (pl)
HU (1) HUP0204417A3 (pl)
IL (1) IL151553A0 (pl)
IS (1) IS6532A (pl)
MX (1) MXPA02008568A (pl)
NO (1) NO20024108L (pl)
NZ (1) NZ520927A (pl)
OA (1) OA12381A (pl)
PE (1) PE20011113A1 (pl)
PL (1) PL365071A1 (pl)
SK (1) SK12542002A3 (pl)
WO (1) WO2001064183A1 (pl)
YU (1) YU66202A (pl)
ZA (1) ZA200206764B (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101237858B (zh) * 2005-07-19 2012-07-04 爱的发 胃滞留制剂及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
ATE460934T1 (de) * 2006-07-19 2010-04-15 Tabuk Pharmaceutical Mfg Co Pharmazeutische zubereitungen von ciprofloxacin
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
US20190070299A1 (en) * 2016-02-23 2019-03-07 Matripharm International Inc. Dual-rate release formulation with high drug loading
CA3018727C (en) 2016-03-24 2024-03-26 The Regents Of The University Of Colorado, A Body Corporate Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
AP1659A (en) * 1998-09-14 2006-09-06 Ranbaxy Laboratories Ltd Orally administered controlled drug delivery system providing temporal and spatial control.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101237858B (zh) * 2005-07-19 2012-07-04 爱的发 胃滞留制剂及其制备方法

Also Published As

Publication number Publication date
IS6532A (is) 2002-08-28
CZ20022883A3 (cs) 2003-04-16
OA12381A (en) 2004-09-06
JP2003525229A (ja) 2003-08-26
EP1263409A1 (en) 2002-12-11
EA200200914A1 (ru) 2003-02-27
HRP20020715A2 (en) 2004-12-31
MXPA02008568A (es) 2003-02-24
HUP0204417A2 (en) 2003-05-28
ZA200206764B (en) 2003-03-04
GT200100033A (es) 2001-10-25
KR20030009374A (ko) 2003-01-29
HUP0204417A3 (en) 2005-03-29
IL151553A0 (en) 2003-04-10
BR0108958A (pt) 2003-09-30
NO20024108L (no) 2002-10-25
CA2400950A1 (en) 2001-09-07
NO20024108D0 (no) 2002-08-28
DOP2001000130A (es) 2004-03-31
PL365071A1 (pl) 2004-12-27
EE200200497A (et) 2004-02-16
AP2001002084A0 (en) 2001-03-31
NZ520927A (en) 2003-06-30
PE20011113A1 (es) 2001-10-14
AP2002002627A0 (en) 2002-09-30
WO2001064183A1 (en) 2001-09-07
AR032614A1 (es) 2003-11-19
AP1485A (en) 2005-10-31
BG107055A (bg) 2003-06-30
HN2001000038A (es) 2005-03-23
YU66202A (sh) 2005-09-19
SK12542002A3 (sk) 2003-05-02
AU3589701A (en) 2001-09-12
ECSP013952A (es) 2002-04-23

Similar Documents

Publication Publication Date Title
CN1186013C (zh) 提供时间和空间控制的口服药物控释系统
CN101636152B (zh) 含有西洛他唑的控释制剂及其制备方法
CN1155368C (zh) 鼻腔给药的粉剂组合物
CN1589139A (zh) 调节释放坦洛新片剂
CN1092956C (zh) 含有曲马多盐的持续释放的药物配方
CN1109328A (zh) 24小时释放甲氧乙心安的持续释放制剂
CN1142780C (zh) 药用组合物
CN1250371A (zh) 用于控制释放活性物质的药物组合物
CN1607947A (zh) 包含3－(3－二甲基氨基－1－乙基－2－甲基－丙基)苯酚并能提供活性成分的延迟释放的药物
CN1642526A (zh) 碱性金属添加剂稳定的阿托伐他汀制剂
CN1196481C (zh) 缓释药物组合物和释放药学活性试剂的方法
CN1496738A (zh) 具有高生物利用率的非诺贝特药物组合物及其制备方法
CN1479614A (zh) 控释氢可酮制剂
CN1874767A (zh) 包含aplindore和其衍生物的缓释药物组合物
CN1950069A (zh) 抗兴奋性神经毒性缓释眼内植入物及相关方法
CN1838945A (zh) 罗匹尼罗的新颖制剂
CN1606438A (zh) 5ht4部分激动剂药物组合物
CN1253497A (zh) 含扑热息痛的吞咽片剂
CN1652753A (zh) 具有改进的生物利用度的克拉霉素制剂
CN1214791C (zh) 喹啉酮衍生物药物组合物及其制备方法
CN1543337A (zh) 可膨胀的胃潴留装置
CN1095665C (zh) 改性释放2－甲基－5－硝基－1－咪唑基－乙醇组合物及其制备和使用方法
CN1662237A (zh) 控释医药组合物
CN1946426A (zh) 用于口服施用HMG－CoA还原酶抑制剂的持续释放制剂和其制备方法
CN1921888A (zh) 盐酸坦舒洛新的口服组合物和包含该组合物的控释颗粒制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned